Fennec Pharmaceuticals (NasdaqCM:FENC) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Company ParticipantsJeff Hackman - CEOPierre S. Sayad - Chief Medical OfficerRobert Andrade - CFOConference Call ParticipantsChase Knickerbocker - Senior Research AnalystMadison El-Saadi - Healthcare Equity Research AnalystRaghuram Selvaraju - Managing Director and Equity Research AnalystNone - AnalystNone - AnalystOperatorGood morning, ladies and gentlemen. Welcome to Fennec Pharmaceuticals' fourth quarter and full year ...